Syzygium cumini inhibits adenosine deaminase activity and reduces glucose levels in hyperglycemic patients

Fundamental and Clinical Pharmacology

Volumn 23, Issue 4, 2009, Pages 501-507

  Bopp, A ^a   De Bona, K S ^a   Belle L P ^a   Moresco, R N ^a   Moretto, M B ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Adenosine deaminase; Human peripheral blood; Hypoglycemic properties; Isoenzymes; Syzygium cumini

Indexed keywords

ADENOSINE DEAMINASE; DIPEPTIDYL PEPTIDASE IV; GLUCOSE; SYZYGIUM CUMINI EXTRACT;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ERYTHROCYTE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IN VITRO STUDY; MALE; MEDICINAL PLANT; PRIORITY JOURNAL;

ADENOSINE DEAMINASE; ADULT; ANTIGENS, CD26; ANTIOXIDANTS; BLOOD GLUCOSE; BRAZIL; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; EUGENIA; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; MALE; MEDICINE, TRADITIONAL; MIDDLE AGED; PLANT EXTRACTS; PLANT LEAVES;

EID: 68749101167     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2009.00700.x     Document Type: Article

References (43)

1. Grover J.K., Yadav S., Vats V. Medicinal plants of India with anti-diabetic potential. J. Ethnopharmacol. (2002) 81 81 100.
2. Helmstädter A. Antidiabetic drugs used in Europe prior to the discovery of insulin. Pharmazie (2007) 62 717 720.
3. Sharma S.B., Nasir A., Prabhu K.M., Murthy P.S. Antihyperglycemic effect of the fruit-pulp of Eugenia jambolana in experimental diabetes mellitus. J. Ethnopharmacol. (2006) 104 367 373.
4. Pandey M., Khan A. Hypoglycaemic effect of defatted seeds and water soluble fibre from the seeds of Syzygium cumini (Linn.) skeels in alloxan diabetic rats. Indian J. Exp. Biol. (2002) 40 1178 1182.
5. Teixeira C.C., Fuchs F.D., Blotta R.M. et al. Effect of tea prepared from leaves of Syzygium jambos on glucose tolerance in nondiabetic subjects. Diabetes Care (1990) 13 907 908.
6. Teixeira C.C., Pinto L.P., Kessler F.H. et al. The effect of Syzygium cumini (L.) skeels on post-prandial blood glucose levels in non-diabetic rats and rats with streptozotocin-induced diabetes mellitus. J. Ethnopharmacol. (1997) 56 209 213.
7. Teixeira C.C., Rava C.A., Mallman da Silva P. et al. Absence of antihyperglycemic effect of jambolan in experimental and clinical models. J. Ethnopharmacol. (2000) 71 343 347.
8. Coimbra T.C., Danni F.F., Blotta R.M., da Periara C.A., Guedes M.D., Graf R.G. Plants employed in the treatment of diabetes mellitus; results of an ethnopharmacological survey in Porto Alegre, Brazil. Fitoterapia (1992) 63 320 322.
9. Prince M.S., Kamalakkannan N., Menon V.P. Syzigium cumini seed extracts reduce tissue damage in diabetic rat brain. J. Ethnopharmacol. (2003) 84 205 209.
10. Villaseñor I.M., Lamadrid M.R. Comparative anti-hyperglycemic potentials of medicinal plants. J. Ethnopharmacol. (2006) 104 129 131.
11. Bhandary M.J., Chandrashekar K.R., Kaveriappa K.M. Medical ethnobotany of the siddis of Uttara Kannada district, Karnataka, India. J. Ethnopharmacol. (1995) 47 149 158.
12. Ratech H., Martiniuk F., Borer W.Z., Rappaport H. Differential expression of adenosine deaminase isozymes in acute leukemia. Blood (1988) 72 1627 1632.
13. Ungerer J.P., Oosthuizen H.M., Bissbort S.H., Vermaak W.J. Serum adenosine deaminase: isoenzymes and diagnostic application. Clin. Chem. (1992) 38 1322 1326.
14. Hitoglou S., Hatzistilianou M., Gougoustamou D., Athanassiadou F., Kotsis A., Catriu D. Adenosine deaminase activity and its isoenzyme pattern in patients with juvenile rheumatoid arthritis and systemic lupus erythematosus. Clin. Rheumatol. (2001) 20 411 416.
15. Aghaei M., Karami-Tehrani F., Salami S., Atri M. Adenosine deaminase activity in the serum and malignant tumors of breast cancer: the assessment of isoenzyme ADA1 and ADA2 activities. Clin. Biochem. (2005) 38 887 891.
16. Hirschhorn R. Adenosine deaminase deficiency. Immunodefic. Rev. (1990) 2 175 198.
17. Richard E., Alam S.M., Arredondo-Vega F.X., Patel D.D., Hershfield M.S. Clustered charged amino acids of human adenosine deaminase comprise a functional epitope for binding the adenosine deaminase complexing protein CD26/dipeptidyl peptidase IV. J. Biol. Chem. (2002) 277 19720 19726.
18. Blackburn M.R., Kellems R.E. Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation. Adv. Immunol. (2005) 86 1 41.
19. Booth C., Hershfield M., Notarangelo L. et al. Management options for adenosine deaminase deficiency; proceedings of the EBMT satellite workshop. Clin Immunol. (2007) 123 139 147.
20. Franco R., Pacheco R., Gatell J.M., Gallart T., Lluis C. Enzymatic and extraenzymatic role of adenosine deaminase 1 in T-cell-dendritic cell contacts and in alterations of the immune function. Crit. Rev. Immunol. (2007) 27 495 509.
21. Baganha M.F., Pêgo A., Lima M.A., Gaspar E.V., Cordeiro A.R. Serum and pleural adenosine deaminase. Correlation with lymphocytic populations. Chest (1990) 97 605 610.
22. da Cunha J.G. Adenosine deaminase. A pluridisciplinary enzyme. Acta Med. Port. (1991) 4 315 323.
23. Canbolat O., Ulusoyduran S., Ö zgen G., Ceyhan I., Gümüslü F., Akbay A. The comparison of adenosine deaminase activity values with polymerase chain reaction results in patient with tuberculosis. J. Clin. Lab. Anal. (1999) 13 209 212.
24. Kurtul N., Pence S., Akarsu E., Kocoglu H., Aksoy Y., Aksoy H. Adenosine deaminase activity in the serum of type 2 diabetic patients. Acta Med. (Hradec Kralove) (2004) 47 33 35.
25. Hoshino T., Yamada K., Masuoka K. et al. Elevated adenosine deaminase activity in the serum of patients with diabetes mellitus. Diabetes Res. Clin. Pract. (1994) 25 97 102.
26. Rutkiewicz J., Górski J. On the role of insulin in regulation of adenosine deaminase activity in rat tissues. FEBS Lett. (1990) 271 79 80.
27. Moresco R.N., Sperotto R.L., Bernardi A.S., Cardoso R.F., Gomes P. Effect of the aqueous extract of Syzygium cumini on carbon tetrachloride-induced hepatotoxicity in rats. Phytother. Res. (2007) 21 793 795.
28. Giusti G., Gakis C. Temperature conversion factors, activation energy, relative substrate specificity and optimum pH of adenosine deaminase from human serum and tissues. Enzyme (1971) 12 417 425.
29. Bergmeyer H.U. Methods of enzymatic analysis. Deerfield Beach (1986) 6 178 184.
30. Prakash M.S., Chennaiah S., Murthy Y.S.R., Anjaiah E., Rao S.A., Suresh C. Altered adenosine deaminase activity in type 2 diabetes mellitus. JIACM (2006) 7 114 117.
31. Mannucci E., Pala L., Ciani S. et al. Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus. Diabetologia (2005) 48 1168 1172.
32. Ryskjaer J., Deacon C.F., Carr R.D. et al. Plasmadipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake. Eur. J. Endocrinol. (2006) 155 485 493.
33. Bailey C.J., Day C. Traditional plant medicines as treatments for diabetes. Diabetes Care (1989) 12 553 564.
34. Brito F.A., Lima L.A., Ramos M.F.S. et al. Pharmacological study of anti-allergic activity of Syzygium cumini (L.) Skeels. Braz. J. Med. Biol. Res. (2007) 40 105 115.
35. Pepato M.T., Folgado V.B.B., Kettelhut I.C., Brunetti I.L. Lack of antidiabetic effect of a Eugenia jambolana leaf decoction on rat streptozotocin diabetes. Braz. J. Med. Biol. Res. (2001) 34 389 395.
36. Jamal Z., Saggerson E.D. Enzymes involved in adenosine metabolism in rat white and brown adipocytes. Effects of streptozotocin-diabetes, hypothyroidism, age and sex differences. Biochem. J. (1987) 245 881 886.
37. Giblett E.R., Anderson J.E., Cohen F. et al. Adenosine deaminase deficiency in two patients with severe impaire cellular immunity. Lancet (1972) 2 1067 1069.
38. Anandharajan R., Jaiganesh S., Shankernarayanan N.P., Viswakarma R.A., Balakrishnan A. In vitro glucose uptake activity of Aegles marmelos and Syzygium cumini by activation of Glut-4, PI3 kinase and PPARgamma in L6 myotubes. Phytomedicine (2006) 13 434 441.
39. Maggirwar S.B., Dhanraj D.N., Somani S.M., Ramkumar V. Adenosine acts as an endogenous activator of the cellular antioxidant defense system. Biochem. Biophys. Res. Comm. (1994) 201 508 515.
40. Dudzinska W., Hlynczak A.J. Purine nucleotides and their metabolites in erythrocytes of streptozotocin diabetic rats. Diabetes Metab. (2004) 30 557 567.
41. Sprague R.S., Stephenson A.H., Bowles E.A., Stumpf M.S., Lonigro A.J. Reduced expression of G(i) in erythrocytes of humans with type 2 diabetes is associated with impairment of both cAMP generation and ATP release. Diabetes (2006) 55 3588 3593.
42. Mest H.J., Mentlein R. Dipeptidyl peptidase inhibitors as new drugs for the treatment of type 2 diabetes. Diabetologia (2005) 48 616 620.
43. Green B.D., Irwin N., Duffy N.A., Gault V.A., O'harte F.P., Flatt P.R. Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1. Eur. J. Pharmacol. (2006) 547 192 199.